Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07278531 · ClinicalTrials.gov registry record · NA
Adaptive Dietary Intervention (ADI) for Asian Americans With Type 2 Diabetes
A NA study, sponsored by NYU Langone Health.
- Not yet
- Registry status
- NA
- Development phase
- 120
- Enrollment target
NCT07278531 is a NA study that has not yet begun recruiting, run by NYU Langone Health. The registered enrollment target is 120 participants.
The verdict
NCT07278531, a NA study, has not yet begun recruiting, sponsored by NYU Langone Health.
- NOT YET RECRUITING
- Registry status
- NA
- Development phase
- 120 participants
- Enrollment target
Study Summary
The investigators will examine the feasibility, acceptability, and effect of an adaptive dietary intervention over 24 weeks (12-week intervention, 12-week follow-up) among Asian Americans with Type 2 diabetes. Participants (N=120; 60 Chinese Americans and 60 Vietnamese Americans) will be 2:1 randomized to one of two arms: adaptive dietary intervention or standard of care (SC). The intervention will begin with continued glucose monitoring (CGM) use only during weeks 0-4. At week 4, participants who achieve the glycemic control goal (at least an 8% increase in time in range \[TIR\] from baseline) will continue with the CGM alone during weeks 4-12 ("CGM Alone"); otherwise, culturally and linguistically adapted glucose excursion minimization (GEM) will be augmented with CGM ("CGM-GEM").
Interventions
- DEVICE Continuous Glucose Monitoring (CGM)
- BEHAVIORAL Adaptive dietary intervention (GEM)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 120 participants |
| Start Date | 2026-02 |
| Est. Completion | 2028-08-31 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07278531
The ClinicalTrials.gov registry entry for NCT07278531 describes a study currently listed as not yet recruiting, categorized as NA. The registered enrollment target is 120 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is NYU Langone Health, which has 1,164 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Continuous Glucose Monitoring (CGM) is the first listed.
NCT07278531 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT07278531 about?
NCT07278531 is a clinical study titled "Adaptive Dietary Intervention (ADI) for Asian Americans With Type 2 Diabetes". The investigators will examine the feasibility, acceptability, and effect of an adaptive dietary intervention over 24 weeks (12-week intervention, 12-week follow-up) among Asian Americans with Type 2 diabetes. Participants (N=120; 60 Chinese Americans and 60 Vietnamese Americans) will be 2:1 randomi...
What is the current status of trial NCT07278531?
This trial is currently not yet recruiting. It is a NA study. The enrollment target is 120 participants. The study started on 2026-02. Estimated completion is 2028-08-31.
What interventions are being tested in trial NCT07278531?
The interventions under investigation include: Continuous Glucose Monitoring (CGM) (DEVICE), Adaptive dietary intervention (GEM) (BEHAVIORAL).
Who is sponsoring clinical trial NCT07278531?
This trial is sponsored by NYU Langone Health, which has 1,164 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.